
The Healthtech industry is up 8.3% in the last week, with Sphere up 33%. During this same period, the NEUROPHET underperformed, falling 12%. This means that the industry has gained 6.1% over the past year. In the next few years, earnings are forecast to decline by 31% annually.
Has the South Korean Healthtech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 13 Feb 2026 | ₩2.8t | ₩590.6b | -₩69,408,221,100.00 | 8.2x | -39.9x | 4.7x |
| Sun, 11 Jan 2026 | ₩2.5t | ₩590.6b | -₩69,408,221,100.00 | 7.5x | -36.6x | 4.3x |
| Tue, 09 Dec 2025 | ₩2.5t | ₩590.6b | -₩69,408,221,100.00 | 7.8x | -35.9x | 4.2x |
| Thu, 06 Nov 2025 | ₩2.6t | ₩587.8b | -₩117,710,536,000.00 | 8.6x | -21.9x | 4.4x |
| Sat, 04 Oct 2025 | ₩2.6t | ₩587.8b | -₩117,710,536,000.00 | 9.8x | -21.9x | 4.4x |
| Mon, 01 Sep 2025 | ₩2.5t | ₩587.8b | -₩117,710,536,000.00 | 10.7x | -20.9x | 4.2x |
| Wed, 30 Jul 2025 | ₩3.2t | ₩581.6b | -₩119,895,420,550.00 | 37.8x | -27x | 5.6x |
| Fri, 27 Jun 2025 | ₩3.2t | ₩581.6b | -₩119,895,420,550.00 | 25.6x | -26.5x | 5.5x |
| Sun, 25 May 2025 | ₩3.0t | ₩580.7b | -₩142,610,869,320.00 | 11.3x | -21.1x | 5.2x |
| Tue, 22 Apr 2025 | ₩3.2t | ₩563.2b | -₩137,189,191,030.00 | 10.9x | -23.1x | 5.6x |
| Thu, 20 Mar 2025 | ₩3.2t | ₩553.4b | -₩144,451,277,440.00 | 9.9x | -22x | 5.7x |
| Sat, 15 Feb 2025 | ₩3.4t | ₩536.1b | -₩85,171,350,030.00 | 10.8x | -39.9x | 6.3x |
| Mon, 13 Jan 2025 | ₩3.2t | ₩536.1b | -₩85,171,350,030.00 | 11.2x | -37.8x | 6x |
| Wed, 11 Dec 2024 | ₩3.4t | ₩536.1b | -₩85,171,350,030.00 | 10.5x | -40.1x | 6.4x |
| Fri, 08 Nov 2024 | ₩2.3t | ₩504.1b | -₩85,882,642,230.00 | 12.8x | -27.3x | 4.6x |
| Sun, 06 Oct 2024 | ₩2.5t | ₩504.1b | -₩85,882,642,230.00 | 13.4x | -29.1x | 5x |
| Tue, 03 Sep 2024 | ₩2.5t | ₩504.1b | -₩85,882,642,230.00 | 14x | -28.9x | 4.9x |
| Thu, 01 Aug 2024 | ₩2.5t | ₩479.3b | -₩114,966,911,080.00 | 17.2x | -21.5x | 5.1x |
| Sat, 29 Jun 2024 | ₩2.8t | ₩479.3b | -₩114,966,911,080.00 | 17.8x | -24.2x | 5.8x |
| Mon, 27 May 2024 | ₩3.1t | ₩473.9b | -₩108,740,202,140.00 | 11.5x | -28.8x | 6.6x |
| Wed, 24 Apr 2024 | ₩3.0t | ₩472.9b | -₩116,225,868,680.00 | 12x | -25.7x | 6.3x |
| Fri, 22 Mar 2024 | ₩3.5t | ₩466.4b | -₩120,119,714,140.00 | 15.1x | -28.9x | 7.4x |
| Sun, 18 Feb 2024 | ₩3.7t | ₩470.3b | -₩126,434,108,550.00 | 18.5x | -29.5x | 7.9x |
| Tue, 16 Jan 2024 | ₩4.1t | ₩473.1b | -₩129,782,846,150.00 | 14.2x | -31.4x | 8.6x |
| Thu, 14 Dec 2023 | ₩4.3t | ₩473.1b | -₩129,782,846,150.00 | 14.8x | -33x | 9.1x |
| Sat, 11 Nov 2023 | ₩4.2t | ₩472.1b | -₩129,827,783,480.00 | 15.1x | -32.6x | 9x |
| Mon, 09 Oct 2023 | ₩3.9t | ₩472.1b | -₩129,827,783,480.00 | 15.9x | -29.9x | 8.2x |
| Wed, 06 Sep 2023 | ₩4.8t | ₩468.0b | -₩119,615,334,030.00 | 17.8x | -40.5x | 10.3x |
| Fri, 04 Aug 2023 | ₩3.8t | ₩460.8b | -₩96,255,067,860.00 | 18.8x | -39.9x | 8.3x |
| Sun, 02 Jul 2023 | ₩3.3t | ₩460.8b | -₩96,255,067,860.00 | 19x | -34.6x | 7.2x |
| Tue, 30 May 2023 | ₩2.4t | ₩462.5b | -₩94,027,082,690.00 | 18.1x | -25.5x | 5.2x |
| Thu, 27 Apr 2023 | ₩2.0t | ₩454.8b | -₩121,205,489,640.00 | 81.1x | -16.2x | 4.3x |
| Sat, 25 Mar 2023 | ₩1.9t | ₩443.0b | -₩112,115,937,030.00 | 21.4x | -17.3x | 4.4x |
| Mon, 20 Feb 2023 | ₩1.9t | ₩446.2b | -₩100,021,271,520.00 | 24.6x | -18.7x | 4.2x |
-18.7x
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -0.68% | |
| Healthcare | -0.49% | |
| Healthtech | 8.28% | |
| Healthtech | 8.28% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A347700 Sphere | ₩38.50k | 33.9% +₩420.0b | 378.3% | PE496.7x | |
| A311690 CJ Bioscience | ₩8.85k | 3.9% +₩4.3b | -9.8% | PS34.3x | |
| A226330 SyntekaBio | ₩3.75k | 3.7% +₩3.3b | -52.9% | PS51x |